Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients

Carcinogenesis

Volumn 19, Issue 5, 1998, Pages 841-846

  Schoket, Bernadette ^a   Phillips, David H ^b   Kostic, Szilárd ^c   Vincze, István ^a  

^a National Institute of Public Health Budapest   (Hungary)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PHOSPHORUS 32;

ADULT; AGED; ARTICLE; BRONCHUS; DNA ADDUCT; FEMALE; GENOTYPE; HALF LIFE TIME; HISTOLOGY; HUMAN; HUMAN TISSUE; HUNGARY; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING;

ADULT; AGED; BRONCHI; CYTOCHROME P-450 CYP1A1; DEOXYRIBONUCLEASE HPAII; DNA ADDUCTS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING;

EID: 0031843886     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.5.841     Document Type: Article

References (66)

1. Doll,R. and Peto,R. (1981) The Causes of Cancer. Oxford University Press, Oxford.
2. IARC (1986) Tobacco Smoking. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 38. IARC, Lyon.
3. Miller,E.C. and Miller,J.A. (1981) Searches for ultimate chemical carcinogens and their reaction with cellular macromolecules. Cancer, 47, 2327-2345.
4. Pelkonen,O. and Nebert,D.W. (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev., 34, 189-222.
5. Phillips,D.H. (1990) Modern methods of DNA adduct determination. In Cooper,C.S. and Grover,P.L. (eds) Handbook of Experimental Pharmacology, vol. 94/I. Springer Verlag, Berlin, Heidelberg, pp. 503-546.
6. Goldstein,J.A. and Faletto,M.B. (1993) Advances in mechanisms of activation and deactivation of environmental chemicals. Environ. Hlth Perspect., 100, 169-176.
7. Petruzelli,S., Camus,A.M., Carrozzi,L. et al. (1988) Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients. Cancer Res., 48, 4695-4700.
8. Yamasaki,H., Inui,Y., Yun,C.H., Guengerich,F.P. and Shimada,T. (1992) Cytochrome P450 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis, 13, 1789-1794.
9. Heckbert,S.R., Weiss,N.S., Hornung,S.K., Eaton,D.L. and Motulsky,A.G. (1992) Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl Cancer Inst., 84, 414-422.
10. Phillips,D.H., Schoket,B., Hewer,A., Bailey,E., Kostic,S. and Vincze,I. (1990) Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer, 46, 569-575.
11. Thompson,C.L., McCoy,Z., Lambert,J.M., Andries,M.J. and Lucier,G.W. (1989) Relationship among benzo[a]pyrene metabolism, benzo[a]pyrene-diol-epoxide:DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. Cancer Res., 49, 6503-6511.
12. Dunn,B.P., Vedal,S., San,R.H.C., Kwan,W.F., Nelems,B., Enarson,D.A. and Stich.,H.F. (1991) DNA adducts in bronchial biopsies. Int. J. Cancer, 48, 485-492.
13. Mooney,L.A., Santella,R.M., Covey,L. et al. (1995) Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol. Biomark. Prev., 4, 627-634.
14. 6-alkylguanine DNA alkyltransferase activity in human lung tissue. Carcinogenesis, 15, 1535-1539.
15. Guengerich,F.P., Shimada,T., Raney,K.D., Yun,C.H., Meyer,D.J., Ketterer,B., Harris,T.M., Groopman,J.D. and Kadlubar,F.F. (1992) Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology. Environ. Hlth Perspect., 98, 75-80.
16. Ketterer,B., Harris,J.M., Talaska,G., Meyer,D.J., Pemble,S.E., Taylor,J.B., Lang,N.P. and Kadlubar,F.F. (1992) The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Hlth Perspect., 98, 87-94.
17. Crofts,F., Taioli,E., Trachman,J., Cosma,G.N., Currie,D., Toniolo,P. and Garte,S.J. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
18. Seidegård,J., Pero,R.W., Miller,D.G. and Beattie,E.J. (1986) A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis, 7, 751-753.
19. Hirvonen,A., Nylund,L., Kociba,P., Husgavfel-Pursiainen,K. and Vainio,H. (1994) Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis, 15, 813-815.
20. Carmella,S.G., Akerkar,S.A., Richie,J.P. and Hecht,S.S. (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomark. Prev., 4, 615-642.
21. Nebert,D.W. (1991) Role of genetics and drug metabolism in human cancer risk. Mutat. Res., 247, 267-281.
22. Guengerich,F.P. and Shimada,T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391-407.
23. Kawajiri,K., Nakachi,K., Imai,K., Yoshii,A., Shinoda,N. and Watanabe,J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett., 263, 131-133.
24. Hayashi,S.I., Watanabe,J., Nakachi,K. and Kawajiri,K. (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem., 110, 407-411.
25. Hirvonen,A., Husgafvel-Pursiainen,K., Antilla,S. and Vainio,H. (1992) Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomark. Prev., 1, 485-489.
26. Mannervik,B. and Danielson,H. (1988) Glutathione transferases - structure and catalytic activity. CRC Crit. Rev. Biochem., 23, 283-337.
27. McWilliams,J.E., Sanderson,B.J.S., Harris.E.L., Richert-Boe,K.E. and Henner,W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 4, 589-594.
28. Shields,P.G., Bowman,E.D., Harrington,A.M., Doan,V.T. and Weston,A. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res., 53, 3486-3492.
29. Ryberg,D., Hewer,A., Phillips,D.H. and Haugen,A. (1994) Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res., 54, 5801-5803.
30. Grinberg-Funes,R.A., Singh,V.N., Perera,F.R., Bell,D.A., Young T.L., Dickey,C., Wang,L.W. and Santella,R.M. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione S-transferase Ml genotype. Carcinogenesis, 15, 2449-2454.
31. Schoket,B., Horkay,I., Kósa,Á., Páldeák,L., Hewer,A., Grover,P.L. and Phillips,D.H. (1990) Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture and in mouse skin and lung following topical application of coal-tar and juniper tar. J. Invest. Dermatol., 94, 241-246.
32. 32P-postlabelling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
33. Phillips,D.H., Hewer,A. and Grover,P.L. (1986) Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. Carcinogenesis, 7, 2071-2075.
34. Zhong,S., Wyllie,A.H., Barnes.D., Wolf,C.R. and Spurr,N.K. (1993) Relationship between GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-1824.
35. Hirvonen,A. Husgafvel-Pursiainen,K., Antilla,S. and Vainio,H. (1993) The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis, 14, 1479-1481.
36. Kato,S., Shields,P.G., Caporaso,N.E., Hoover,R.N., Trump,B.F., Sugimura,H., Weston,A. and Harris,C.C. (1992) Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res., 52, 6712-6715.
37. Hirvonen,A., Husgavfel-Pursiainen,K., Anttila,S. and Vainio,H. (1993) The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis, 14, 85-88.
38. Katoh.T., Inatomi,H., Nagaoka,A. and Sugita,A. (1995) Cytochrome P4501 A1 gene polymorphism and homozygous deletion of the glutathione S-transferase Ml gene in urothelial cancer patients. Carcinogenesis, 16, 655-657.
39. Lin,H.J., Han,C.Y., Bernstein,D.A., Hsiao,W., Lin,B.K. and Hardy,S. (1994) Ethnic distribution of the glutathione transferase Mu1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis, 15, 1077-1081.
40. Bell,D.A., Taylor,J.A., Paulson,D.F., Robertson,C.N., Mohler,J.L. and Lucier,G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 85, 1159-1164.
41. Warwick,A., Sarhanis,P., Redman,C. et al. (1994) Theta class glutathione S-transferases GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1. CYP2D6 and smoking. Carcinogenesis, 15, 2841-2845.
42. Phillips,D.H. and Farmer,P.B. (1995) Protein and DNA adducts as biomarkers of exposure to environmental mutagens. In Phillips,D.H. and Venitt,S. (eds) Environmental Mutagenesis. Bios Scientific Publishers Ltd, Oxford, pp. 367-395.
43. 32P-post-labeling assay. J. Natl Cancer Inst., 81, 341-347.
44. Cuzick,J., Routledge,M.N., Jenkins,D. and Garner,R.C. (1990) DNA adducts in different tissues of smokers and non-smokers. Int. J. Cancer, 45, 673-578.
45. Perera,F., Mayer,J., Jaretzki,A. et al. (1989) Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Res., 49, 4446-4451.
46. Weston,A. and Bowman,E.D. (1991) Fluorescence detection of benzo[a]pyrene-DNA adducts in human lung. Carcinogenesis, 12, 1445-1449.
47. Corley,J., Hurtubise,R.J., Bowman,E.D. and Weston,E. (1995) Solid matrix, room temperature phosphorescence identification and quantitation of tetrahydrotetrols derived from the acid hydrolysis of benzo[a]pyrene-DNA adducts from human lung. Carcinogenesis, 16, 423-426.
48. Alexandrov,K., Rojas,M., Geneste,O., Castegnaro,M., Camus,A.-M., Petruzelli,S., Giuntini,C. and Bansch,H. (1992) An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res., 52, 6248-6253.
49. Schoket,B., Kostic,S. and Vincze,I. (1993) Determination of smoking-related DNA adducts in lung-cancer and non-cancer patients. In Phillips,D.H., Castegnaro,M. and Bartsch,H. (eds) Postlabelling Methods for Detection of DNA Adducts. IARC, Lyon, pp. 315-319.
50. Phillips,D.H., Hewer,A., Martin,C.N., Garner,R.C. and King,M.M. (1988) Correlation of DNA adduct levels in human lung with cigarette smoking. Nature, 336, 790-792.
51. Szyfter,K., Hemminki,K., Szyfter,W., Szmeja,Z., Banaszewszki,J. and Young,K. (1994) Aromatic DNA adducts in larynx biopsies and leukocytes. Carcinogenesis, 15, 2195-2199.
52. Stone,J., Jones,N.J., McGregor,A.D. and Waters,R. (1995) Development of a human biomonitoring assay using buccal mucosa: Comparison of smoking-related DNA adducts in mucosa versus biopsies. Cancer Res., 55, 1267-1270.
53. 32P-post-labeling analysis. Carcinogenesis, 18, 339-344.
54. Talaska,G., Al-Juburi,A.Z.S.S. and Kadlubar,F.F. (1991) Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: Identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl Acad. Sci. USA, 88, 5350-5354.
55. Phillips,D.H. and Ni Shé,M. (1994) DNA adducts in cervical tissue of smokers and non-smokers. Mutat. Res., 313, 277-284.
56. Tang,D., Santella,R.M., Blackwood,A.M., Young,T.-L., Mayer.J., Jaretzki,A., Grantham,S., Tsai,W.-T. and Perera,F.P. (1995) A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomark. Prev., 4, 341-346.
57. Anttila,S., Hietanen,E., Vainio,H., Camus,A.-M., Gelboin,H.V., Park,S.S., Heikkilä,L., Karjalainen,A. and Bartsch,H. (1991) Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer, 47, 681-685.
58. 32P-post-labelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis, 12, 1301-1305.
59. Crofts,F., Taioli,E., Trachman,J., Cosma,G.N., Currie,D., Toniolo,P. and Garte,S.J. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
60. Board,P., Coggan,M., Johnston,P., Ross,V., Suzuki,T. and Webb,G. (1990) Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmac. Ther., 48, 357-369.
61. Anttila,S., Hirvonen,A., Vainio,H., Husgafvel-Pursiainen,K., Hayes,J.D. and Ketterer,B. (1993) Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res., 53, 5643-5648.
62. Ryberg,D., Skaug,V., Hewer,A. el at. (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285-1289.
63. Kato,S., Bowman,E.D., Harrington,A.M., Blomeke,B. and Shields,P.G. (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl Cancer Inst., 87, 902-907.
64. Hou,S.-M., Lambert,B. and Hemminki,K. (1995) Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis, 16, 1913-1917.
65. Hemminki,K., Dickey,C., Karlsson,S., Bell,D., Hsu,Y., Tsai,W.-Y., Mooney,L.A., Savela,K. and Perera,F.P. (1997) Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis, 18, 345-350.
66. Ichiba,M., Hagmar,L., Rannug,A., Högstedt,B., Alexandrie,A.K., Carstensen,U. and Hemminki,K. (1994) Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTT1 in chimney sweeps. Carcinogenesis, 15, 1347-1352.